Whether you’re in clinical development, preparing for launch, or assessing post-approval impact, tap into the world’s most extensive patient data, analytics, and tech-driven solutions to inform evidence-based decisions every step of the way.
Discovery
Patient & disease understanding
Biomarker development
Target identification
Clinical development
Trial design: Inclusion / exclusion & endpoints
Standard of care characteristics
Target product profiling
Interventional & non-interventional studies
Regulatory approval
Evidence generation
Natural history of disease
Treatment pathways
Incidence and prevalence
Identify suitable comparators
External control arm
Label change / expansion
HTA / market access
Evidence generation
Burden of disease
Cost of illness
Differentiation studies
External control arm
Outcomes studies
Comparative effectiveness
Treatment patterns
Post-launch
PAES & PMR
RWE supporting conditional approval
RWE enhancing brand value proposition
RWE on treatment patterns across geographies and patient subgroups
Powering global real-world evidence generation
Draw on data from our proprietary catchment that includes 175 million+ patients from healthcare and research organizations around the world – Europe, Japan, APAC, and the U.S. We’ll apply your research objectives to identify, ingest, harmonize, and integrate the right data sources to ensure your projects are set up for success from Day One.
175M+
patients accessible
35+
countries represented
>90%
patients ex-US
150+
data partnerships
Shorten timelines and accelerate speed to insight
Get seamless, compliant, and secure access to research-ready RWD to support evidence generation across R&D and commercialization activities. Rich mastered data sets that include harmonized and integrated granular patient data provide the reliable foundation you need for discussions with payers, regulators, and other key stakeholders across the entire value chain.
Global patient data
Explore extensive curated datasets that include clinical data, EMRs, eCRFs, labs, multi-omics, imaging data and more across oncology, neurology, rare diseases, immunology, and cardiology. And, we can easily integrate your own data to further enrich your analysis.
Quickly identify patient cohorts, select biomarkers, and analyze standard of care patterns with BC Catalyst, a prompt-based precision medicine platform that makes complex genomic and real-world clinical data actionable across the entire drug lifecycle.
Get standardized, large-scale imaging datasets that are research-ready and anonymized. BC Image accelerates time-to-data and enables advanced, AI-driven analytics for drug development and precision medicine.
Have confidence that data access is well-managed, secure and in compliance with governance standards. Commission analyses from our experts or conduct your own in a built-for-purpose trusted research environment – federated options available.
Get expert support for your trial planning and execution needs from our Scientific Services team, including protocol development and statistical analysis plans (SAP), data science services spanning epidemiology, biostatistics and programming, and medical and regulatory report writing.
Expert data harmonization and integration
As experts in data management and stewardship, we bring proven technology, tools, and experience for processing, analyzing, and sharing sensitive data. Our data mastering platform, BC Unify, transforms and anonymizes multi-modal healthcare data — both structured and unstructured — into harmonized, standardized, analytics-ready datasets.